TABLE 3.

Multivariate analysis of overall survival in 315 LIHC patients.

	Coef	HR	95%CI_l	95%CI_u	p-value	Sig
Age	0.016	1.016	0.999	1.034000e + 00	0.069	■
Gendermale	0.052	1.053	0.669	1.659000e + 00	0.823
Stage2	0.246	1.278	0.747	2.186000e + 00	0.370
Stage3	0.797	2.220	1.358	3.628000e + 00	0.001	**
Stage4	1.399	4.050	1.088	1.507300e + 01	0.037	*
Purity	1.060	2.886	0.866	9.619000e + 00	0.084	■
B_cell	–8.621	0.000	0.000	5.150000e-01	0.034	*
CD8_Tcell	–7.538	0.001	0.000	1.420000e-01	0.008	**
CD4_Tcell	–10.041	0.000	0.000	2.820000e-01	0.025	*
Macrophage	14.026	1234392.939	744.103	2.047734e + 09	0.000	***
Neutrophil	–3.010	0.049	0.000	6.370710e + 04	0.675
Dendritic	5.785	325.352	3.888	2.722593e + 04	0.010	*
CLEC4A	–0.158	0.854	0.380	0.380	1.916000e + 00
CLEC4C	2.644	14.069	0.054	3.680792e + 03	0.352
CLEC4D	–1.122	0.326	0.005	2.095100e + 01	0.598
CLEC4E	0.295	1.343	0.663	2.721000e + 00	0.414
CLEC4F	–0.409	0.664	0.208	2.120000e	0.490
CLEC4G	–0.593	0.553	0.300	1.017000e + 00	0.057	■
ASGR1	0.379	1.461	1.063	2.007000e + 00	0.019	*
ASGR2	–0.241	0.786	0.786	0.569	1.085000e + 00
FCER2	0.836	2.307	1.097	4.849000e + 00	0.027	*
CD207	0.253	1.287	0.955	1.736000e + 00	0.098	■
CD209	–0.048	0.953	0.632	1.436000e + 00	0.817

***p < 0.001; ** p < 0.01;* p < 0.05; ■ 0.05 < p < 0.1.